About: Hidemichi Watari

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hidemichi Watari Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) onderzoeker (nl) investigador xaponés (ast)
rdfs:label	Hidemichi Watari (en) Hidemichi Watari (nl) Hidemichi Watari (tr) Hidemichi Watari (ast) 渡利英道 (ja)
skos:prefLabel	Hidemichi Watari (en) Hidemichi Watari (nl) Hidemichi Watari (tr) Hidemichi Watari (ast) 渡利英道 (ja)
name	Hidemichi Watari (en) Hidemichi Watari (nl) Hidemichi Watari (tr) Hidemichi Watari (ast) 渡利英道 (ja)
given name	wds:Q88405179-f54408fd-44c2-a2d6-2ba1-a45553cb0aef
given name	Hidemichi
instance of	wds:Q88405179-E8979D2C-346A-4E2B-9850-C2AC78199618
instance of	Homo sapiens
Researchmap ID	wds:Q88405179-399d2603-438f-3e69-8c64-3f739bb2e8bb
Researchmap ID	watarih
occupation	wds:Q88405179-D71E8C1D-A217-4BF2-85B0-333CD6D7AB88
employer	wds:Q88405179-5b72065d-4867-cf73-984e-9f3586bedbed
CiNii Research ID	wds:Q88405179-83F7FB57-28E5-409E-AD29-4E22356B6103
sex or gender	wds:Q88405179-384fc65e-420a-69f8-0052-c72e0d893a45
country of citizenship	wds:Q88405179-bbf1c5e9-416d-f038-5797-cefdf0515d89
J-GLOBAL ID	wds:Q88405179-2b9967a5-4166-1fef-9feb-949e630b27cd
CiNii Research ID	https://cir.nii.ac.jp/crid/1420845751136134784.rdf
occupation	researcher
employer	Hokkaido University
CiNii Research ID	1420845751136134784
sex or gender	male
country of citizenship	Japan
J-GLOBAL ID	201401064784256134
ORCID iD	wds:Q88405179-9D66CF9F-0ABE-46AE-AAEA-3E2E9615427E
ORCID iD	https://orcid.org/0000-0002-4189-6187
ORCID iD	0000-0002-4189-6187
e-Rad researcher number	wds:Q88405179-cbc44166-4dd7-8bc9-4050-422e11b39e43
e-Rad researcher number	10344508
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q88405179
is author of	Retracted: Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Proposal of a concept and design of a randomized phase III trial investigating the survival effect of para-aortic lymphadenectomy in endometrial cancer Apoptosis and molecular targeting therapy in cancer Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system Emerging therapeutic biomarkers in endometrial cancer Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype. Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study Tumor volume successively reflects the state of disease progression in endometrial cancer. Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients? Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report. A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy Risk factors for lower-limb lymphedema after surgery for cervical cancer Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Bax, Bcl-2, and p53 expression in endometrial cancer Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel. A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer. Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials. Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling. Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34. Adjuvant chemotherapy for early-stage cervical cancer Neoadjuvant chemotherapy for locally advanced cervical cancer Chemotherapy and molecular targeting therapy for recurrent cervical cancer microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells. Multivariate survival analysis of the patients with recurrent endometrial cancer Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software